TransMedics Group, Inc. (TMDX) Operating cash flow 2018–2025
TransMedics Group, Inc. (TMDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$192.8MFY2025 · since FY2018: -$26.0M → $192.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $192.8M | +295.1% |
| FY2024 | $48.8M | +474.6% |
| FY2023 | -$13.0M | +71.6% |
| FY2022 | -$45.8M | -58.7% |
| FY2021 | -$28.9M | +4.6% |
| FY2020 | -$30.3M | +6.3% |
| FY2019 | -$32.3M | -24.3% |
| FY2018 | -$26.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice